Sherif Ahmed, Ph.D., Pharm.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurilemmoma | 8 | 2023 | 522 | 3.690 |
Why?
|
| Salmonella typhimurium | 3 | 2023 | 348 | 1.540 |
Why?
|
| CARD Signaling Adaptor Proteins | 2 | 2022 | 164 | 1.280 |
Why?
|
| Gene Transfer Techniques | 4 | 2022 | 1216 | 1.120 |
Why?
|
| Dependovirus | 4 | 2022 | 721 | 1.100 |
Why?
|
| Genetic Vectors | 6 | 2022 | 3404 | 0.880 |
Why?
|
| Lentivirus | 5 | 2017 | 518 | 0.740 |
Why?
|
| Myelin P0 Protein | 1 | 2019 | 15 | 0.650 |
Why?
|
| Myelin Proteins | 1 | 2019 | 212 | 0.610 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2019 | 93 | 0.590 |
Why?
|
| Motor Neurons | 1 | 2017 | 869 | 0.400 |
Why?
|
| Spinal Cord | 2 | 2017 | 1784 | 0.390 |
Why?
|
| Transgenes | 3 | 2022 | 1015 | 0.360 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2019 | 916 | 0.350 |
Why?
|
| Injections, Intralesional | 2 | 2022 | 281 | 0.330 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2022 | 3608 | 0.310 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 2880 | 0.310 |
Why?
|
| Transduction, Genetic | 3 | 2022 | 898 | 0.310 |
Why?
|
| Apoptosis | 2 | 2022 | 9514 | 0.280 |
Why?
|
| Immunotherapy | 1 | 2022 | 4752 | 0.260 |
Why?
|
| Mice | 11 | 2023 | 81819 | 0.230 |
Why?
|
| Skin Neoplasms | 1 | 2023 | 5849 | 0.220 |
Why?
|
| Gene Expression | 4 | 2022 | 7584 | 0.200 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2021 | 59 | 0.180 |
Why?
|
| Animals | 12 | 2023 | 168764 | 0.170 |
Why?
|
| Vestibulocochlear Nerve | 1 | 2019 | 115 | 0.160 |
Why?
|
| Neurofibromatosis 2 | 1 | 2021 | 387 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2022 | 2476 | 0.140 |
Why?
|
| Neoplasms, Experimental | 1 | 2022 | 1229 | 0.140 |
Why?
|
| Neuroma, Acoustic | 1 | 2019 | 456 | 0.120 |
Why?
|
| Hearing | 1 | 2019 | 505 | 0.120 |
Why?
|
| Virus Integration | 2 | 2014 | 304 | 0.120 |
Why?
|
| Injections | 1 | 2017 | 840 | 0.120 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 17075 | 0.110 |
Why?
|
| Inflammasomes | 1 | 2019 | 543 | 0.110 |
Why?
|
| Viral Envelope Proteins | 1 | 2017 | 640 | 0.110 |
Why?
|
| Uterus | 1 | 2017 | 661 | 0.110 |
Why?
|
| Adenoviridae | 1 | 2017 | 1092 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2034 | 0.110 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 781 | 0.100 |
Why?
|
| Tumor Burden | 1 | 2019 | 1885 | 0.100 |
Why?
|
| Chondroitin ABC Lyase | 1 | 2011 | 15 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 1 | 2019 | 6113 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 18293 | 0.090 |
Why?
|
| HEK293 Cells | 2 | 2017 | 4260 | 0.090 |
Why?
|
| Fetus | 1 | 2017 | 1870 | 0.090 |
Why?
|
| Respiratory Mucosa | 1 | 2012 | 438 | 0.080 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 595 | 0.080 |
Why?
|
| Plasmids | 1 | 2014 | 2274 | 0.080 |
Why?
|
| Cell Survival | 1 | 2019 | 5747 | 0.080 |
Why?
|
| Mitosis | 1 | 2014 | 1173 | 0.080 |
Why?
|
| Motor Activity | 1 | 2019 | 2704 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2022 | 11022 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2019 | 5786 | 0.070 |
Why?
|
| Biological Transport | 1 | 2012 | 2081 | 0.070 |
Why?
|
| Spinal Cord Injuries | 2 | 2012 | 927 | 0.070 |
Why?
|
| Sodium | 1 | 2012 | 1591 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 1167 | 0.070 |
Why?
|
| Pain | 1 | 2021 | 5077 | 0.060 |
Why?
|
| Humans | 12 | 2023 | 765968 | 0.060 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 802 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2019 | 4424 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7478 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2022 | 65188 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10429 | 0.050 |
Why?
|
| Sciatic Neuropathy | 1 | 2021 | 75 | 0.040 |
Why?
|
| Oxygen | 1 | 2012 | 4241 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2012 | 3681 | 0.040 |
Why?
|
| Neurons | 1 | 2019 | 9525 | 0.040 |
Why?
|
| Prognosis | 1 | 2019 | 29922 | 0.040 |
Why?
|
| Pregnancy | 1 | 2017 | 30260 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 23601 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 5767 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2021 | 3618 | 0.030 |
Why?
|
| Matrix Attachment Regions | 1 | 2014 | 3 | 0.030 |
Why?
|
| Replication Origin | 1 | 2014 | 78 | 0.030 |
Why?
|
| DNA, Circular | 1 | 2014 | 97 | 0.030 |
Why?
|
| Male | 4 | 2021 | 363698 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 805 | 0.020 |
Why?
|
| CHO Cells | 1 | 2014 | 1372 | 0.020 |
Why?
|
| Clone Cells | 1 | 2014 | 1672 | 0.020 |
Why?
|
| Cricetinae | 1 | 2014 | 2411 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 2012 | 661 | 0.020 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2012 | 479 | 0.020 |
Why?
|
| Muscular Atrophy | 1 | 2012 | 335 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 2011 | 249 | 0.020 |
Why?
|
| Sheep | 1 | 2011 | 1440 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2014 | 2060 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 11888 | 0.020 |
Why?
|
| Rats | 2 | 2012 | 23707 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2014 | 2867 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2014 | 6069 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 2140 | 0.010 |
Why?
|
| Female | 2 | 2021 | 396112 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 3655 | 0.010 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2012 | 1484 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 22223 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 15543 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2011 | 18973 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 40065 | 0.010 |
Why?
|